Stock Screener App

무료 -

16.49

0.55% +0.09

Catalyst Pharmaceuticals Inc (CPRX)

개요 뉴스 가격 이력 옵션 체인 Financials CPRX 왜 하락? 토론 예측

Catalyst Pharmaceuticals Inc 주식(CPRX)의 최신 뉴스

Jump Financial LLC Has $1.08 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Amalgamated Bank Reduces Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Victory Capital Management Inc. Reduces Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Victory Capital Management Inc. Decreases Stock Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Catalyst Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Boston Partners Grows Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat

Implied Volatility Surging for Catalyst Pharmaceuticals (CPRX) Stock Options - Yahoo Canada Shine On

Yahoo Canada Shine On

2 Incredible Growth Stocks to Buy Hand Over Fist Right Now

The Motley Fool

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings Estimates - Yahoo Movies UK

Yahoo Movies UK

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Catalyst Pharmaceuticals (NASDAQ:CPRX) PT Raised to $26.00 - Defense World

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Sold by New York State Common Retirement Fund - Defense World

StockNews.com Lowers Catalyst Pharmaceuticals (NASDAQ:CPRX) to Hold - Defense World

Catalyst Pharmaceuticals (NASDAQ:CPRX) Downgraded to "Hold" at StockNews.com - MarketBeat

Catalyst Pharmaceuticals (CPRX) Stock Forecast and Price Target 2024 - MarketBeat

Relay Therapeutics, Inc. (RLAY) Surges 13.8%: Is This an Indication of Further Gains? - Yahoo Movies Canada

Yahoo Movies Canada

Los Angeles Capital Management LLC Sells 41330 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

HC Wainwright Increases Catalyst Pharmaceuticals (NASDAQ:CPRX) Price Target to $26.00 - MarketBeat

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript - Insider Monkey

Decoding 8 Analyst Evaluations For Catalyst Pharmaceuticals - Catalyst Pharmaceuticals (NASDAQ:CPRX) - Benzinga

Catalyst Pharmaceuticals First Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St

(CPRX) Investment Analysis and Advice - Stock Traders Daily

Stock Traders Daily

Earnings call: Catalyst Pharmaceuticals Q1 2024 shows robust growth - Investing.com South Africa

Investing.com South Africa

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Earnings call: Catalyst Pharmaceuticals Q1 2024 shows robust growth - Investing.com Canada

Investing.com Canada

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues - Yahoo Finance

Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues - Zacks Investment Research

Zacks Investment Research

Cantor Fitzgerald Maintains Catalyst Pharmaceuticals (CPRX) Overweight Recommendation - MSN

Catalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - 08.05.2024 - wallstreet:online

wallstreet:online

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - br.ADVFN.com

Catalyst (CPRX) Up More Than 20% in Past 3 Months: Here's Why - Yahoo Movies UK

Yahoo Movies UK

Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Recursion (RXRX) to Report Q1 Earnings: What's in the Cards?

Zacks Investment Research

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: What's in Store?

Zacks Investment Research

Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?

Zacks Investment Research

Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Yousif Capital Management LLC Sells 3164 Shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World

Catalyst Pharmaceutical (CPRX) Gains But Lags Market: What You Should Know - Yahoo Movies UK

Yahoo Movies UK

Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks Investment Research

Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

$77.56

0.77%

$149.40

1.20%

$29.98

1.11%

$172.85

1.06%

$365.81

2.87%

$90.61

2.55%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기